Drug-Eluting Stents: Technical and Clinical Progress

19Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

Drug-eluting stents (DES) demonstrated superior efficacy when compared to bare metal stents and plain-old balloon angioplasty and are nowadays used in almost all percutaneous revascularization procedures. The design of the stent platforms is constantly improving to maximize its efficacy and safety. Constant development of DES includes adoption of new materials used for scaffold production, new design types, improved overexpansion abilities, new polymers coating and, finally, improved antiproliferative agents. Especially nowadays, with the immense number of available DES platforms, it is crucial to understand how different aspects of stents impact the effect of their implantation, as subtle differences between various stent platforms could impact the most important issue—clinical outcomes. This review discusses the current status of coronary stents and the impact of stent material, strut design and coating techniques on cardiovascular outcomes.

Cite

CITATION STYLE

APA

Koźlik, M., Harpula, J., Chuchra, P. J., Nowak, M., Wojakowski, W., & Gąsior, P. (2023, March 1). Drug-Eluting Stents: Technical and Clinical Progress. Biomimetics. MDPI. https://doi.org/10.3390/biomimetics8010072

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free